Home › Breast Cancer › Indiana › Gary
Breast Cancer clinical trials in Gary, IN
4 studies for Breast Cancer are looking for participants at sites in and around Gary (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Woodland Cancer Care Center, Michigan City · 25 mi away
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecruitingPhase 3
- UChicago Medicine Northwest Indiana, Crown Point · 12 mi away
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RecruitingPhase 3
- St. Mary Medical Center, Hobart · 6 mi away
- Northwest Cancer Center, Crown Point · 12 mi away
- Northwest Cancer Center, Valparaiso · 17 mi away
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RecruitingPhase 3
- Northwest Cancer Center - Hobart, Hobart · 6 mi away
- Saint Mary Medical Center, Hobart · 6 mi away
- Northwest Cancer Center - Main Campus, Crown Point · 12 mi away
- and 2 more
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. Learn about the types, diagnosis, and treatments.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY144 studies
- Houston, TX126 studies
- Boston, MA110 studies
- Nashville, TN78 studies
- Los Angeles, CA73 studies
- Edison, NJ70 studies
- Queens, NY67 studies
- Durham, NC63 studies
- St. Louis, MO63 studies
- Chicago, IL59 studies
- Dallas, TX54 studies
- Philadelphia, PA51 studies
Other studies in Gary
- Non-Small Cell Lung Cancer7 studies
- Lung Cancer7 studies
- Acute Myeloid Leukemia5 studies
- Heart Failure5 studies
- Ovarian Cancer4 studies
- Atrial Fibrillation4 studies
- COPD3 studies
- Blood Clots3 studies
- Esophageal Adenocarcinoma3 studies
- Endometrial Cancer3 studies
- Head and Neck Squamous Cell Carcinoma3 studies
- Bladder Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.